Sort
39,280 grants matching “leukemia”
Nup98 Gene Rearrangements in Acute Myelogenous Leukemia
$324,278Nabeel R Yaseen · Washington University · R01 · FY2008 · HL
The mechanism of Arg kinase activation by integrin B1
$324,267Anthony J Koleske · Yale University · R01 · FY2014 · GM
The mechanism of Arg kinase activation by integrin B1
$324,255Anthony J Koleske · Yale University · R01 · FY2015 · GM
BIOMARKERS OF TREATMENT RELATED LEUKEMIA
$324,253Children'S Hospital Of Philadelphia · R01 · FY2000 · CA
ASSESSING THE THERAPEUTIC WINDOW FOR FUTURE ANTI-NOTCH DIMERIZATION AGENTS
$324,211Raphael Kopan · Cincinnati Childrens Hosp Med Ctr · R01 · FY2013 · CA
The role and functional mechanism of TET1 in MLL-rearranged leukemia
$324,194Jianjun Chen · University Of Chicago · R01 · FY2014 · CA
HUMAN DENDRITIC CELLS AND THE ONSET OF INNATE AND ADAPTIVE IMMUNITY IN ALLOGENEIC
$324,177James W. Young · Sloan-Kettering Inst Can Research · P01 · FY2009 · CA
HEMATOPOIESIS AND LEUKEMIC TRANSFORMATION IN FAC MICE
$324,144Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2002 · HL
Cell Manipulation
$324,122Jerome Ritz · Dana-Farber Cancer Inst · P30 · FY2015 · CA
Endogenous CNTF receptors and adult, in vivo neurogenesis
$324,117Alexander John Maclennan · University Of Cincinnati · R01 · FY2013 · NS
Nonmyeloablative Hematopoietic Cell Allotransplants
$324,112Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2014 · CA
Regulation of Chemokine Mediated Leukocyte Functions
$324,096Micheler Ricardo Richardson · North Carolina Central University · R01 · FY2009 · AI
The Genetic Analysis of Mitochondrial Iron Metabolism
$324,075Diane McVey Ward · University Of Utah · R01 · FY2016 · DK
The Genetic Analysis of Mitochondrial Iron Metabolism
$324,075Jerry Kaplan · University Of Utah · R01 · FY2014 · DK
The Genetic Analysis of Mitochondrial Iron Metabolism
$324,075Jerry Kaplan · University Of Utah · R01 · FY2015 · DK
Development of mechanism-based ovarian reserve protecting adjuvant therapies against gonadotoxic therapeutic agents
$324,063So-Youn Kim · University Of Nebraska Medical Center · R01 · FY2019 · HD
Development of mechanism-based ovarian reserve protecting adjuvant therapies against gonadotoxic therapeutic agents
$324,063So-Youn Kim · University Of Nebraska Medical Center · R01 · FY2020 · HD
Chronic Myelogenous Leukemia and Bcr-Abl Substrates
$324,063Oregon Health And Science University · R01 · FY2005 · CA
CDK6 in T cell development and cancer
$324,053Philip W Hinds · Tufts Medical Center · R01 · FY2012 · CA
Role of TGFBI gene in cell proliferation and tumor progression
$324,053Yongliang Zhao · Columbia University Health Sciences · R01 · FY2011 · CA
CDK6 in T cell development and cancer
$324,053Philip W Hinds · Tufts Medical Center · R01 · FY2011 · CA
Microvesicle Dynamics in B-Cell Chronic Lymphocytic Leukemia Tumor Microenvironme
$324,048Asish Kumar Ghosh · Mayo Clinic Rochester · R01 · FY2013 · CA
TOR kinase inhibitors for leukemia therapy: mechanisms of action and resistance
$324,025David A Fruman · University Of California-Irvine · R01 · FY2012 · CA
Epigenetic regulation of thrombopoiesis
$324,000Margarida Santos · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · HL
Non-Invasive Monitoring of CRISPR/Cas-Edited Chimeric Antigen Receptor T (CAR-T) Cells with Reporter Gene-Based Magnetic Resonance Imaging and Positron Emission Tomography
$324,000John Andrew Ronald · University Of Western Ontario · UH3 · FY2022 · EB